Clinical trials

Condition   Drug Name  
Study Rupatadine in urticaria
Design Randomized; Pooled/meta-analysis
Patients 582
Treatment Regimen Rupatadine, 5 mg o.d. x 6 wks; Rupatadine, 10 mg o.d. x 6 wks; Rupatadine, 20 mg o.d. x 6 wks; Placebo
Conclusions Rupatadine was safe and well tolerated in patients with chronic urticaria
Reference(s) Safety profile of rupatadine in the treatment of chronic urticaria
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1354.
Author and Affiliation Giménez-Arnau, A., Malbran, A., Poop, G., Benea, V., Medina, I., Garcia, O., Donado, E.